Can a "center effect" explain the higher frequency of inhibitors for a second generation recombinant factor VIII product?

H Marijke van den Berg, Rolf Ljung

Forskningsoutput: Tidskriftsbidrag › Letter › Peer review

Originalspråk	engelska
Sidor (från-till)	2164-2165
Tidskrift	Blood
Volym	126
Nummer	18
DOI	https://doi.org/10.1182/blood-2015-08-663583
Status	Published - 2015

Ämnesklassifikation (UKÄ)

Hematologi

Tillgång till dokument

10.1182/blood-2015-08-663583

http://www.ncbi.nlm.nih.gov/pubmed/26392597?dopt=Abstract

Citera det här

@article{4055dee5f96847ab8bdffe48f7d770b6,

title = "Can a {"}center effect{"} explain the higher frequency of inhibitors for a second generation recombinant factor VIII product?",

author = "{van den Berg}, {H Marijke} and Rolf Ljung",

year = "2015",

doi = "10.1182/blood-2015-08-663583",

language = "English",

volume = "126",

pages = "2164--2165",

journal = "Blood",

issn = "1528-0020",

publisher = "American Society of Hematology",

number = "18",

}

TY - JOUR

T1 - Can a "center effect" explain the higher frequency of inhibitors for a second generation recombinant factor VIII product?

AU - van den Berg, H Marijke

AU - Ljung, Rolf

PY - 2015

Y1 - 2015

U2 - 10.1182/blood-2015-08-663583

DO - 10.1182/blood-2015-08-663583

M3 - Letter

C2 - 26392597

SN - 1528-0020

VL - 126

SP - 2164

EP - 2165

JO - Blood

JF - Blood

IS - 18

ER -